R&D Systems™ Human MFG-E8 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 2767MF050
DescriptionThe Recombinant Human MFG-E8 Protein is derived from NS0. The Recombinant Human MFG-E8 Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2 μm filtered solution in NaH 2 PO 4 and NaCl.|
|40-58 kDa, reducing conditions|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Mouse myeloma cell line,NS0-derived human MFG-E8 protein Leu24-Cys387,with a C-terminal 6-His tag|
|90%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok